| Venue: |
Tokyo Keidanren Kaikan |
| Speaker: |
Hospital Director of Harada Hospital in Japan
Doctor of Medical Science Masayoshi Harada |
| |
Dr. Harada consistently holds a strong conviction about providing the best service to his patients and seeks the latest science. He is the one of the pioneers that has verified the accurate liver function laboratory value by experiment for more than 45 years.
|
| <Topic> |
The clinical effect of YHK for more than 200 examples including hepatitis B and C virus, fatty liver, hepatic cirrhosis and fulminant hepatitis |
| m o r e → |
| Speaker: |
Professor of Milano University in Italy
Doctor of Medical Science Francesco Marotta |
| |
Prof. F. Marotta is a specialist in Gastroenterology and internationaly famous as energetic researcher. He is the only Italian professor who presented research paper in Japanese with his five years research experience in Japan National Cancer Center. |
| <Topic> |
Phytotherapy in liver disease: Challenges and opportunities of YHK to fill the gap of pharmacotherapy |
| m o r e → |
| Speaker: |
Associate Professor of Medicine of University of Western Ontario in Canada
Doctor of Medical Science Paul Marotta |
| |
Prof. P. Marotta is a specialist in Gastroenterology and the Medical Director of Liver Transplantation in Canada. He is the participant and leader of several Canadian National projects. His latest research paper showing the clinical research of NASH has been accepted by internationally hi-level magazine "diseases and sciences". This conference is his first visit in Japan.
|
| <Topic> |
Liver Disease and the role of YHK. |
| m o r e → |
- American Institute for Cancer Research (AICR) Annual Conference on Food, Nutrition, Physical Activity and Cancer 2008/11/6 ~ 7
Inhibitory Action of a Novel Phytotherapeutic Compound Against Human Hepatoma Cells
- American Institute for Cancer Research (AICR) Annual Conference on Food, Nutrition, Physical Activity and Cancer 2008/11/6 ~ 7
Phytotherapeutic Compound YHK Experts an Inhibitory Effect on Early Stage of Experiment Ally-Induced Neoplastic Liver Lesions
- International Symposium on: Functional Foods in Europe – International Developments in Science and Health Claims 2007/5/9 ~ 11
Phytotherapeutic compound YHK exerts an inhibitory effect on early stage of experimentally-induced neoplastic liver lesions
- Springer 2007Year
Nonalcoholic Steatohepatitis (NASH) in OB/OB Mice Treated with Yo Jyo Hen Shi Ko (YHK): Effects on Peroxisome Proliferator-Activated Receptors (PPARs) and Microsomal Triglyceride Transfer Protein (MTP)
- Annals of Hepatology 2006Year
Phytotherapeutic compound YHK exerts an inhibitory effect on early stage of experimentally-induced neoplastic liver lesions
- Digestive Diseases and Sciences 2006Year
Yo Jyo Hen Shi Ko (YHK) Improves Transaminases in Nonalcoholic Steatohepatitis (NASH): A Randomized Pilot Study
- 1st Annual Canadian Association for the Study of the Liver Winter Meeting: Updates in Hepatology 2005/03/19 ~ 22
Yo Jyo Hen Shi Ko (YHK) ImprovesTransaminases in Nonalcoholic Steatohepatitis(NASH): A Randomized Pilot Study
- 7th International ISSX Meeting 2004/8/29 ~ 9/2
An In Vitro Study on the Beneficial Effect of YHK, A Natural Herbal Compound, on Metal-Induced Oxidative Damage of Hepatocytes and Mithocondrial Fraction
- First JSH Single Topic Conference 2002/11/14 ~ 15
AWARD-WINNING: YHK, A Novel Herbal Remedy with Effective Antifibrotic Action, in Chronic Liver Disease: A Pilot Clinical Study Aiming to a Successful Integrative Medicine Development
- First JSH Single Topic Conference 2002/11/14 ~ 15
Is There Any Liver Anti-Fibrotic Effect of K-17.22? An Experimental Study with Immunohistochemical Analysis in A Rat Model
- First JSH Single Topic Conference 2002/11/14 ~ 15
Effect of K-17.22, a Novel Phytoterapeutic Agent, on DNA Synthesis and Liver Enzyme Release in Experimental Liver Damage
- HEP DART 2001 2001/12/16 ~ 20
Effect of "Yojyo Henshiko (YHK)", in Patients with Hepatic Diseases
- The 4th Annual Meeting of the Japanese Society for Alternative Medicine and Treatment 2001/11/10
The Effect of the Tablets
- The 43th The Journal of All Japan Hospital Association 2001/10/20
The Effect of the Yojyo Hen Shi Ko for the liver diseases -Specially for the Hepatitis Type C
- European Association for the Study of the Liver 2001/10/12 ~ 13
Beneficial Effect of a Controlled Chinese Herbal Remedy, K-17.22, in CCL4-Induced Liver Toxicity; an in Vivo and in Vitro Study
- 25th National Congress of the Italian Association of Pancreatology Study 2001/9/20 ~ 22
A Nutritional Approach with Herbal Remedy K-17.22 Delays the Onset of Spontaneous Chronic Pancreatitis
- 4th JSH International Symposium on Liver Cirrhosis & Liver Cancer; 37th Annual Meeting of Liver Cancer Study Group of Japan 2001/6/7 ~ 9
Ischemia-Reperfusion Liver Injury: Effect of a Nutritional Approach with K-17.22 on Eudogenous Hepatic Antioxidant System
- IASL-APASL JOINT MEETING 2000 2000/6/2 ~ 7
Effect of "Yojyo Henshiko: A New Chinese Herb Prescription" on Serum Alt and AST Levels in Patients with Hepatic Diseases
- 3rd International Conference on Therapies for Viral Hepatitis 1999/12/12 ~ 16
Effect of "Yojyo Henshiko, a new Chinese Herb Prescription", on Serum ALT and AST Levels in Patients with Hepatic Diseases
- 2nd Annual Meeting of the Japanese Society for Alternative Medicine & Treatment 1999/10/10 ~ 11
Clinical Application and Efficacy of a New Chinese Medical Herb Prescription: "Yojyo Henshiko"
|
|
